Tin tức & Cập nhật

Original New Drug Application Approvals by US FDA (16 - 31 May 2022

07 Aug 2024

New drug applications approved by US FDA as of 16-31 May 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 May 2022

07 Aug 2024

Android and Java app introduced for amputee profiling

06 Aug 2024 bởi

An application for Android and Java enabled phones called ASCeNT or Amputee Screening through Cellphone Networking was developed by Ateneo Java Wireless Competency Center and Smart Communications, Inc. With a mobile solution for amputee profiling, people from distant areas can be assessed through submitted reports from the application and referred to specialists when necessary; which also makes follow-up care is more convenient. A version for iOS devices is being developed.

Android and Java app introduced for amputee profiling

06 Aug 2024

Diagnosing functional dyspepsia difficult, but simple tests can help

02 Aug 2024 bởi

Functional dyspepsia’s general symptom profile can make identification difficult but a number of simple tests can help to distinguish it from other, often concurrent, gastrointestinal diseases.

Diagnosing functional dyspepsia difficult, but simple tests can help

02 Aug 2024

ACOG article 2.7

04 Jul 2024 bởi

Treatment with fezolinetant significantly reduced the frequency and severity of vasomotor symptoms (VMS), particularly hot flashes, in women during their menopausal phase, according to the SKYLIGHT 1* trial presented at ACOG 2022.

ACOG article 2.7

04 Jul 2024

[MK TEST DO NOT TOUCH] Trifarotene clears acne battle scars

18 Mar 2024 bởi

Individuals dealing with the stubborn scars and hyperpigmentation left behind by acne may find benefit in trifarotene cream – the newest among the new generation of topical retinoids approved for acne treatment, according to the findings of two vehicle-controlled, phase IV studies presented at AAD 2024.